FDA Advisory Committee Votes Unanimously that FC2 Female Condom(R) is ...(has more than tripled -- from 8 percent ...),Health

Date:12/12/2008

has more than tripled -- from 8 percent of PLHIV in 1985 to 26 percent in 2007. HIV infection has emerged as the leading cause of death for African American women aged 25-34, high-risk heterosexual contact is responsible for 80 percent of new HIV infections among American women, and one in four young adults aged 15-20 years contracts a sexually transmitted infection each year.

In this context, expanded access to the female condom -- the only safe, effective, and available woman-initiated prevention method currently available -- can provide women and men with more options to practice safer sex and prevent unintended pregnancy.

About The Female Health Company

The Female Health Company (FHC), headquartered in Chicago, IL, is the maker of the FC1 Female Condom and the FC2 Female Condom, woman-initiated prevention methods offering dual protection against sexually transmitted infections, including HIV/AIDS, and unintended pregnancy. FHC was created as a worldwide company in February 1996 with the purchase of Chartex Resources, Ltd., the holder of exclusive worldwide rights to the FC1 Female Condom. The Company holds exclusive product and technology patents for the FC1 Female Condom in the U.S., Australia, Brazil, Canada, France, Germany, Italy, Spain, the United Kingdom, the People's Republic of China, South Korea and Japan. Patents are pending for the FC2 Female Condom. FHC is the sole worldwide manufacturer and marketer of the FC1 Female Condom and the FC2 Female Condom.

The Female Health Company and its partners currently market the Female Condom under FC Female Condom(R), FC2 Female Condom(R), Reality(R), Femidom(R), Femy(R), and Care(R) in the rest of the world.

For more information about the Female Health Company, visit the Company's website at http://www.femalehealth.com and

SOURCE Female Health Company Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5
Related medicine news :

1. GlaxoSmithKline Statement on FDA Advisory Committee Vote on Use of Asthma Medicines Containing Long-Acting Beta-Agonists
2. AANMA Provides Commentary to FDA Advisory Committees Reviewing Benefit-Risk Assessment of 12 Hour Bronchodilators
3. New Health Care Advisory Board to Advise PNC on Billing, Payments and Financial Management
4. PharmMD Expands Advisory Board
5. U.S. Labor Secretary Elaine L. Chao announces new membership of OSHA advisory committee
6. Pennsylvania DEP Directs Shadyside Water Supply to Issue Boil Water Advisory
7. Advisory Vote Begins on California Long-Term Care Local
8. Governors Advisory Council on Physical Fitness and Sports Awards Presented by Health
9. Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2008 Third Quarter Results
10. Medipacs Appoints Advisory Board Members
11. Skinvisible Appoints Dr. Geert Cauwenbergh to Its International Advisory Board